Percheron Therapeutics Limited Stock
Stocks
PER
AU0000317281
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Australian S.E.
2026-09-09
|
5-day change | 1st Jan Change | ||
| 0.004500 AUD | +12.50% |
|
-10.00% | -50.00% |
| 08-31 | Percheron Therapeutics Limited Announces Board Changes | CI |
| 08-18 | Percheron Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| Market Cap | 6.85M 4.91M 4.23M 4.01M 3.63M 6.82M 469M 47.61M 18.31M 239M 18.45M 18.05M 755M | P/E 2027 * |
-0.96x | P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 6.85M 4.91M 4.23M 4.01M 3.63M 6.82M 469M 47.61M 18.31M 239M 18.45M 18.05M 755M | EV / Sales 2027 * |
7.61x | EV / Sales 2028 * | - |
| Free-Float |
97% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PER | End-of-day quote | |
OTC Markets
| PERCF | Delayed | |
|
Deutsche Boerse AG
| AWY0 | Delayed | |
|
Börse Stuttgart
| AWY0 | Delayed | |
|
Tradegate
| AWY0 | Real-time | |
|
Boerse Muenchen
| AWY0 | Real-time |
| 1 day | +12.50% | ||
| 1 week | -10.00% | ||
| Current month | -10.00% | ||
| 1 month | +12.50% | ||
| 3 months | +12.50% | ||
| 6 months | -30.77% | ||
| Current year | -50.00% |
| 1 week | 0 |  | 0.01 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.01 |
| 3 years | 0 | | 0.14 |
| 5 years | 0 | | 0.35 |
| 10 years | 0 | | 0.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 52 | 2024-06-16 | |
| Chief Tech/Sci/R&D Officer | - | 2025-09-22 | |
Eugene Kennedy
CTO | Chief Tech/Sci/R&D Officer | 57 | 2025-09-22 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
Ben Price
BRD | Director/Board Member | 70 | 2021-10-03 |
| Director/Board Member | 52 | 2026-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/31/24 | Buy | Chairman | 1,666,666 | 0.1533% | ||
| 12/26/24 | Buy | Chief Executive Officer | 1,500,000 | 0.1379% | ||
| 12/20/24 | Expiration | Chairman | 6,667 | 0.0006% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +12.50% | -10.00% | -50.00% | -93.38% | 4.91M | |
| -0.71% | -6.35% | -2.99% | +9.59% | 45.48B | |
| +0.21% | -2.98% | +337.74% | +519.55% | 43.68B | |
| +1.74% | -2.24% | +39.82% | +20.76% | 43.09B | |
| +1.38% | -3.28% | +6.84% | +67.62% | 39.4B | |
| -1.44% | -5.26% | +8.97% | +39.76% | 31.91B | |
| +0.87% | -2.60% | - | - | 17.31B | |
| +0.75% | -0.64% | +19.75% | +110.17% | 16.4B | |
| -0.31% | -2.78% | +10.78% | +31.02% | 14.24B | |
| +1.93% | -3.55% | +82.00% | +41.17% | 13.28B | |
| Average | +1.69% | -4.22% | +50.32% | +82.92% | 26.48B | |
| Weighted average by Cap. | +0.41% | -3.67% | +74.56% | +124.25% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 900K 645K 556K 527K 477K 895K 61.67M 6.25M 2.41M 31.37M 2.42M 2.37M 99.14M | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-09 | A$0.004500 | +12.50% | 100,000 |
| 26-09-08 | A$0.004000 | -33.33% | 4,950,370 |
| 26-09-07 | A$0.006000 | +20.00% | 8,045,827 |
| 26-09-04 | A$0.005000 | 0.00% | 194,584 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- PER Stock
Select your edition
All financial news and data tailored to specific country editions
